Intelligent Bio Solutions Inc

INBS

Company Profile

  • Business description

    Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

  • Contact

    135 West, 41ST Street
    5th Floor
    New YorkNY10036
    USA

    T: +1 646 828-8258

    E: [email protected]

    https://www.ibs.inc

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    55

Stocks News & Analysis

stocks

Ask the analyst: Can this genius product create the next ASX software king?

Siteminder’s newly released product for hotel owners and travel agents could widen its moat and see revenue accelerate further.
stocks

Impact of ANZ’s huge fine

Working to prevent repeated failures could also improve competitiveness.
stocks

Acquisition a sign of weakness for overvalued ASX share

Acquisition unlikely to improve prospects in the US and detracts from other opportunities.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,147.604.90-0.05%
CAC 407,896.9371.690.92%
DAX 4023,748.8650.710.21%
Dow JONES (US)45,883.4549.230.11%
FTSE 1009,277.036.26-0.07%
HKSE26,446.5658.400.22%
NASDAQ22,348.75207.640.94%
Nikkei 22544,932.56164.440.37%
NZX 50 Index13,210.572.260.02%
S&P 5006,615.2830.990.47%
S&P/ASX 2008,875.105.60-0.06%
SSE Composite Index3,860.5010.09-0.26%

Market Movers